Site-specific antibody labeling via endo-S2 mediated Fc glycan remodeling
Methods in Enzymology · 2026 · 485-501
DOI: 10.1016/bs.mie.2026.05.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Methods in Enzymology, 2026. Verfasst von D Natasha Owitipana und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, University of Maryland, College Park, Maryland, United States. Hauptthemen laut MEDLINE: Trastuzumab, Immunoglobulin Fc Fragments, Polysaccharides, Glycoside Hydrolases. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Site-specific labeling of antibodies is highly valuable for diagnostic and therapeutic applications. The chemoenzymatic Fc glycan remodeling method provides a platform for site-specific antibody functionalization without perturbing antigen recognition. In this chapter, we describe a one-pot enzymatic method to produce fluorophore- and biotin-labeled antibodies using S. pyogenes endoglycosidase S2 (Endo-S2) as the enzyme and functionalized disaccharide oxazolines as the substrate. This method enables the efficient installation of azide, biotin, or fluorophore functionalities at the Fc glycosylation site, yielding homogeneous antibody conjugates. Trastuzumab, a therapeutic monoclonal antibody, was chosen as the model antibody for this protocol but the platform should also be applicable for other recombinant IgG antibodies. This protocol offers a robust and modular approach for preparing site-specifically labeled antibodies for various applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry, University of Maryland, College Park, Maryland, United States.
- Department of Chemistry and Biochemistry, University of Maryland, College Park, Maryland, United States. Electronic address: wang518@umd.edu.
Förderung
- NIAID NIH HHS
- National Institutes of Health
Zitieren
APA
Owitipana, D. N., Wang, X., Zhang, X., & Wang, L. X. (2026). Site-specific antibody labeling via endo-S2 mediated Fc glycan remodeling. Methods in Enzymology, 485-501. https://doi.org/10.1016/bs.mie.2026.05.002
Vancouver
Owitipana DN, Wang X, Zhang X, Wang LX. Site-specific antibody labeling via endo-S2 mediated Fc glycan remodeling. Methods in Enzymology. 2026:485-501. doi:10.1016/bs.mie.2026.05.002
BibTeX
@article{Owitipana2026,
author = {Owitipana, D Natasha and Wang, Xianyang and Zhang, Xiao and Wang, Lai-Xi},
title = {Site-specific antibody labeling via endo-S2 mediated Fc glycan remodeling},
journal = {Methods in Enzymology},
year = {2026},
pages = {485--501},
doi = {10.1016/bs.mie.2026.05.002}
}
EUVIMED